Clinical application of the UroLift prostatic urethral lift in Spain: consensus on the treatment of lower urinary tract symptoms associated with urinary flow obstruction and secondary to benign prostatic hyperplasia (BPH).

Autores de IIS La Fe

• Alberto Budía Alba

  Autor

Participantes ajenos a IIS La Fe

• Fernandez Arjona, M
• Lopez Martin, L
• Herranz Fernandez, L M
• Sinues Ojas, B
• Campa Bortolo, J M
• Extramiana Cameno, J
• Lopez Alcina, E
• Povo Martin, I
• Ordaz Jurado, G
• Osca Garcia, J M
• Peran Teruel, M
• Gimeno Argente, V
• Navarro Beltran, A
• Benejam Gual, J
• Hernandez Martinez, Y E
• Gonzalez Enguita, C

Grupos

• Urología

Abstract

Benign prostatic hyperplasia (BPH) is an increasingly common pathology in the adult male. BPH increases after the age of 40-45 years, and its management consumes an enormous amount of resources. The UroLift System is an approved technology designed to treat lower urinary tract symptoms (LUTS) secondary to BPH and is used to perform the prostatic urethral lift (PUL) procedure. Various urology specialists in Spain with experience in PUL have prepared this consensus document. Endorsed by the Spanish Urology Association, its information is based on the most recent findings. The main objective of this document is to disseminate the consensus recommendations among all professionals treating patients with LUTS/BPH. Both primary care physicians and urologists can assess and offer PUL as an effective, minimally invasive treatment.

Copyright © 2024 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Keywords

• Benign prostatic hyperplasia (BPH); Consensus document; Documento de consenso; Elevación de la uretra prostática (EUP); Hiperplasia benigna de próstata (HBP); Lower urinary tract symptoms (LUTS); Prostatic urethral lift (PUL); Sistema UroLift®; Síntomas del tracto urinario inferior (STUI); UroLift® system